Acheson M B, Patton R G, Howisey R L, Lane R F, Morgan A
Multidisciplinary Team, Seattle Breast Center, Northwest Hospital, USA.
Arch Surg. 1997 Aug;132(8):815-8; discussion 819-21. doi: 10.1001/archsurg.1997.01430320017002.
To examine the histologic correlation between image-guided large-core needle biopsy (LCNB) and excisional biopsy of nonpalpable breast lesions.
Histologic findings of LCNB and excision specimens were reviewed for patients who underwent image-guided LCNB of nonpalpable breast lesions from April 1, 1993, to March 31, 1996. Histologic diagnosis of the excision specimen was used as a criterion standard. Follow-up ranged from 1 to 4 years.
A dedicated breast imaging clinic on the campus of an urban community hospital.
Five hundred fifty-two patients with nonpalpable mammographically detected abnormalities.
Histologic diagnoses of LCNB and excision specimens (part of a prospectively designed, ongoing quality audit process).
Histologic findings were benign in 389 LCNB specimens (70.5%) and abnormal in 163 (29.5%). The benign LCNB specimens remained benign on clinical and radiologic follow-up, with 1 missed malignant diagnosis. One hundred seventy-three patients underwent excision following LCNB, resulting in 10 benign and 163 abnormal specimens. Diagnoses of 102 LCNB specimens showing invasive cancer were confirmed on excision. Of 54 patients in whom LCNB specimens showed ductal carcinoma in situ (DCIS), 10 showed DCIS plus invasive cancer on excision. Of 6 patients in whom LCNB specimens showed atypical duct hyperplasia (ADH), 1 was benign, 1 showed ADH and invasive cancer, 3 showed ADH and DCIS, and 1 remained ADH exclusively on excision. The histologic diagnosis for 10 benign LCNBs remained benign after excision. Correlation coefficient was 0.93 (P < .001).
Benign disease and invasive cancer of the breast can be diagnosed with a high level of confidence using image-guided LCNB. The histologic diagnosis for patients whose LCNB specimens show ADH or DCIS may change after excision.
探讨影像引导下粗针穿刺活检(LCNB)与不可触及乳腺病变切除活检的组织学相关性。
回顾1993年4月1日至1996年3月31日期间接受影像引导下不可触及乳腺病变LCNB患者的LCNB及切除标本的组织学结果。以切除标本的组织学诊断作为标准对照。随访时间为1至4年。
城市社区医院校园内的一家专门的乳腺影像诊所。
552例乳腺X线检查发现不可触及异常的患者。
LCNB及切除标本的组织学诊断(前瞻性设计、正在进行的质量审核过程的一部分)。
389例LCNB标本组织学结果为良性(70.5%),163例(29.5%)为异常。良性LCNB标本在临床及影像学随访中仍为良性,漏诊1例恶性病变。173例患者在LCNB后接受了切除,切除标本中10例为良性,163例为异常。102例LCNB标本显示浸润性癌,切除后确诊。54例LCNB标本显示导管原位癌(DCIS)的患者中,10例切除后显示DCIS合并浸润性癌。6例LCNB标本显示非典型导管增生(ADH)的患者中,1例为良性,1例显示ADH合并浸润性癌,3例显示ADH合并DCIS,1例切除后仅为ADH。10例良性LCNB切除后的组织学诊断仍为良性。相关系数为0.93(P <.001)。
使用影像引导下LCNB可高度准确地诊断乳腺良性疾病和浸润性癌。LCNB标本显示ADH或DCIS的患者切除后的组织学诊断可能会改变。